BERGAGGIO, ELISA
 Distribuzione geografica
Continente #
EU - Europa 317
NA - Nord America 309
AS - Asia 78
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 711
Nazione #
US - Stati Uniti d'America 305
IT - Italia 231
CN - Cina 53
SE - Svezia 18
IE - Irlanda 15
UA - Ucraina 13
DE - Germania 7
AT - Austria 6
JP - Giappone 6
FR - Francia 5
CA - Canada 4
FI - Finlandia 4
GB - Regno Unito 4
KR - Corea 4
IN - India 3
RO - Romania 3
SN - Senegal 3
VN - Vietnam 3
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
HK - Hong Kong 2
PL - Polonia 2
SG - Singapore 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IR - Iran 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 711
Città #
Torino 87
Turin 54
Chandler 47
Fairfield 25
Novara 25
Beijing 22
Ashburn 19
Cambridge 19
Woodbridge 18
Dublin 15
Wilmington 13
Houston 12
Jacksonville 10
New York 10
Bologna 9
Nyköping 9
Seattle 9
Fremont 7
Vienna 6
Ann Arbor 5
Jinan 5
Medford 5
Guangzhou 4
Latina 4
Ottawa 4
Pisa 4
Princeton 4
Rome 4
Dearborn 3
Dong Ket 3
Durham 3
Heidelberg 3
Nanjing 3
Redwood City 3
San Diego 3
San Francisco 3
San Mateo 3
Suzhou 3
Brussels 2
Cadoneghe 2
Flushing 2
Galati 2
Geneve 2
Lecce 2
Serravalle Scrivia 2
Shanghai 2
Singapore 2
Upper Marlboro 2
Villeurbanne 2
Warsaw 2
Xian 2
Yuba City 2
Zhengzhou 2
Ankara 1
Ascoli Piceno 1
Auckland 1
Berlin 1
Boardman 1
Braintree 1
Canberra 1
Caselle Torinese 1
Central District 1
Centrale 1
Centreville 1
Chongqing 1
Clarks Summit 1
Düsseldorf 1
Edinburgh 1
Grugliasco 1
Hangzhou 1
Hefei 1
Helsinki 1
Los Angeles 1
Madrid 1
Medellín 1
Milan 1
Norwalk 1
Palermo 1
Portland 1
Richmond 1
Rochester 1
Seoul 1
São Paulo 1
Tokyo 1
Trieste 1
Verona 1
Wigan 1
Wuhan 1
Yuseong-gu 1
Totale 551
Nome #
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 387
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 154
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 95
Wild-type idh enzymes as actionable targets for cancer therapy 73
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 9
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer 5
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma 2
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells 2
Totale 727
Categoria #
all - tutte 1.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 6 0
2019/2020116 0 1 1 10 8 12 25 14 14 14 7 10
2020/2021166 13 18 7 5 22 15 11 11 14 22 15 13
2021/2022115 4 12 14 8 4 3 7 3 13 14 20 13
2022/2023155 16 22 4 17 11 32 4 7 19 7 12 4
2023/202477 6 10 6 2 3 12 5 14 0 10 9 0
Totale 727